> ## Content Index
> Fetch the complete content index at: https://www.frenchtechjournal.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# 🔥Hot Seed Deals: Hephaistos-Pharma, VoltR, Klineo & Edonia
- URL: https://www.frenchtechjournal.com/hot-seed-deals-hephaistos-voltr-klineo-edonia/
- Published: 2024-05-16T11:12:15.000Z
- Updated: 2024-05-16T11:12:15.000Z
- Description: Deep Tech and Health Tech continue to attract early-stage investors.
- Author: Helen O'Reilly-Durand
- Tags: Funding News

![HEPHAISTOS-Pharma sécurise 10,3 M€ pour aller jusqu'en clinique | MyPharma  Editions](https://www.frenchtechjournal.com/content/images/2024/05/data-src-image-8588e13e-1a22-407e-bcfc-d878ad85a013.jpeg)

**What:** [**Hephaistos-Pharma**](https://hephaistos-pharma.fr/?ref=frenchtechjournal.com)**,** a biotech startup developing treatments to stimulate the immune system to fight cancer.

**Why:** Emerging next-generation immunotherapies have the potential to increase patient cure rates.

**Funding:** €4.5 million Seed Round + €5.8 million non-dilutive funding from the EIC accelerator, Bpifrance iNov, and France 2030 clinical grant.   
‌‌  
**Who:** Co- founders [Martine Caroff](https://www.linkedin.com/in/martine-caroff-79952417/?ref=frenchtechjournal.com) & [Frédéric Caroff](https://www.linkedin.com/in/frederic-caroff/?ref=frenchtechjournal.com)

‌**Investors**: Elaia, Xista Science Ventures, Fondation Fournier-Majoie, Noshaq, Angels Santé & Femmes Business Angels.

**What's next:** The new funding will finance the industrialization of drug production and regulatory toxicity studies to submit a marketing authorization application in Europe.

![](https://www.frenchtechjournal.com/content/images/2024/05/image-2.png)

**What:** [**VoltR**](https://www.voltr.tech/?ref=frenchtechjournal.com)**,** a producer of reconditioned lithium batteries.

**Why:** To industrialize lithium battery reconditioning in Europe.

**Funding:** €4 million  
‌‌  
**Who:** Co- founders [Maxime Bleskine](https://www.linkedin.com/in/maxime-bleskine-39b40810b/%60?ref=frenchtechjournal.com), [Alban Regnier](https://www.linkedin.com/in/alban-regnier-3b879b48/?ref=frenchtechjournal.com), [François Mallet](https://www.linkedin.com/in/fran%C3%A7ois-mallet-1846b962/?ref=frenchtechjournal.com), [Thibaud Maufront](https://www.linkedin.com/in/thibaud-maufront-16329847/?ref=frenchtechjournal.com)

‌**Investors**: C4 Ventures, Exergon, Pays de la Loire Participations & Anjou Amorçage.

**What's next:** With the funds raised, VoltR will continue the initial stages of the company's development, including optimizing reconditioning processes, Research & Development, and recruiting new talents. Fundraising for its Series A round is underway and the company expects it to be completed by the fourth quarter of 2024.

![](https://www.frenchtechjournal.com/content/images/2024/05/klineo.png)

**What:** [**Klineo**](https://www.klineo.fr/?ref=frenchtechjournal.com)**,** a digital health startup that uses an AI-based platform that connects doctors and patients directly with relevant clinical trials.

**Why:** More patients are willing to participate in trials of experimental treatments, but often don't know about them.

**Funding:** €2 million  
‌‌  
**Who:** Co- founders [Thomas Peyresblanques](https://www.linkedin.com/in/thomas-peyresblanques/?ref=frenchtechjournal.com) & [Dr Arnaud Bayle](https://www.linkedin.com/in/arnaud-bayle-034b9668/?originalSubdomain=fr&ref=frenchtechjournal.com)

‌**Investors**: Bpifrance & various Business Angels

**What's next:** Currently, the platform notably covers clinical trials in breast cancer, skin cancer & lymphoma. The new funding will go towards enabling it to cover all cancers in France by the end of 2024.

![](https://www.frenchtechjournal.com/content/images/2024/05/edonia.png)

**What:** [**Edonia**](https://www.edonia.com/?ref=frenchtechjournal.com)**,** a B2B ingredient supplier in the field of protein materials.

**Why:** To produce healthy, high-protein alternatives to meat using ingredients based on microalgae (spirulina, chlorella).

**Funding:** €2 million  
‌‌  
**Who:** Co- founders [Hugo Valentin](https://www.linkedin.com/in/hugo-valentin-05a75774/?ref=frenchtechjournal.com) & [Florent Malbranche](https://www.linkedin.com/in/florentmalbranche/?ref=frenchtechjournal.com)

‌**Investors**: Asterion Ventures, Bpifrance & various Business Angels including Alexis Angot (Ynsect), Laurent Cardinali (Danone, Mondelez), Hugo Dupuis (Umiami), Samuel Nahon (Terroirs d’Avenir), Anne Cabotin (Symrise)

**What's next:** The fresh cash will enable the company to industrialize its technology and extend its R&D.